ASHRLD 2011 | Panel Discussion Case 4

ASHRLD11 - A 54-year-old woman with MM and normal cytogenetics receives lenalidomide, bortezomib and dexamethasone (RVD) on the SWOG-S0777 study followed by maintenance lenalidomide. Case discussion moderated by Neil Love, MD. Produced by Research To Practice.